logo
logo
Search For Features
/
StocksStocks
Intraday BoosterIntraday Booster
Sector BoosterSector Booster
Stock ScreenerStock Screener
Market PulseMarket Pulse
ScreenersScreeners
MoreMore
prime iconGo Prime
My PlansMy Plans
Privacy PolicyPrivacy Policy
ContactContact
Refer & EarnRefer & Earn
ScreenersScreeners
Main
Stock ScreenerStock Screener
Create ScreenerCreate Screener
Explore ScreenersExplore Screeners
Community ScreenersCommunity Screeners
Trading Screeners
CandleSticks ScreenerCandleSticks Screener
Top Gainers & LosersTop Gainers & Losers
Opening Range BreakoutOpening Range Breakout
Stock Screener AIStock Screener AI
Stock Quality ScorecardStock Quality Scorecard
Overvalued StocksOvervalued StocksNew
Undervalued StocksUndervalued StocksNew
Technical Screeners
NR4 StocksNR4 Stocks
NR7 StocksNR7 Stocks
Previous Day High BreakoutPrevious Day High Breakout
Previous Day Low BreakoutPrevious Day Low Breakout
Previous Day Open BreakoutPrevious Day Open Breakout
Bullish Crossover StocksBullish Crossover Stocks
Bearish Crossover StocksBearish Crossover Stocks
High Volume ShockerHigh Volume Shocker
VWAP Breakout StocksVWAP Breakout Stocks
Range High BreakoutRange High Breakout
Range Low BreakoutRange Low Breakout
MoreMore
Markets
Global Market TodayGlobal Market Today
Global IndicesGlobal Indices
Indian IndicesIndian Indices
NIfty TodayNIfty Today
Smart Money
FII DII DataFII DII DataNew
FII BuyingFII Buying
NSE Insider TradingNSE Insider Trading
SLB Stocks DataSLB Stocks Data
Derivatives
FnO MovementsFnO Movements
NSE F&O Lot SizeNSE F&O Lot Size
Ban ListBan List
Analysis & Calendars
Technical DashboardTechnical Dashboard
Sector BoosterSector Booster
Sector AnalysisSector AnalysisNew
Result CalendarResult Calendar
Economic CalendarEconomic Calendar
Apollo Hospitals Enterprise Ltd

Apollo Hospitals Enterprise

Large Cap•83,147 Employees•IPO 1995
Current Price
₹7803.00
24 (0.31%)Updated
NSE :APOLLOHOSP
BSE :508869
Sector :Health Care Providers & Services
Today's Range
₹7770.00
₹7803.00
union icon
₹7870.00
52 Week Range
52W Low₹6002.00
52W High₹8099.50
₹7803.00
union icon
Downside30.01%
Upside3.80%
chart iconChart

Price Chart

Compare with Peers

Historical Ratios

Track top 12 most important financial ratios

P/E Ratio: Price to Earnings - Most used valuation metric

Loading chart...

Analyzing Investment Quality

Processing 9 key metrics...

Key Metrics

Hover for details

Valuation

Market Cap
₹1,09,228.89 Cr
Market Cap
Total market value of company
P/E Ratio
65.46
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)
P/B Ratio
11.72
P/B Ratio
Price to Book Value. <3 may indicate undervaluation
EPS
₹116.28
EPS
Earnings Per Share. Higher and growing is positive

Profitability

ROE
10.02%
ROE
Return on Equity. >15% is good, >20% is excellent
ROCE
16.60%
ROCE
Return on Capital Employed. >15% is good
Net Margin
7.19%
Net Margin
Net profit as % of revenue. >10% is good
Operating Margin
-%
Operating Margin
Operating profit margin. >15% is good

Growth

EPS Growth (5Y)
25.18%
EPS Growth (5Y)
5-year EPS growth. >15% is strong
Revenue Growth (5Y)
14.15%
Revenue Growth (5Y)
5-year revenue growth. >10% is good
Qtr Sales Growth
14.90%
Qtr Sales Growth
Quarter-over-quarter sales growth
Qtr Profit Growth
41.80%
Qtr Profit Growth
Quarter-over-quarter profit growth

Financial Health

Debt/Equity
0.96
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellent
Book Value
₹571.15
Book Value
Net asset value per share
Dividend Yield
0.38%
Dividend Yield
Annual dividend as % of price. >2% is good
Promoter Holding
28.00%
Promoter Holding
Promoter stake. >50% shows confidence
Good
Average
Needs Attention

SWOT Analysis

Strengths

5 points
  • •Substantial market capitalization of ₹112952 Cr indicates strong market presence.
  • •Healthy ROE of 18.4% and ROCE of 16.6% show efficient capital use.

Weaknesses

5 points
  • •Elevated P/E ratio of 71.80 suggests potential overvaluation compared to earnings.
  • •Debt-to-equity ratio of 0.96 indicates relatively high leverage, posing financial risk.

Opportunities

5 points
  • •Robust growth in the healthcare sector presents significant expansion opportunities.
  • •Strong FII (44.20%) and DII (21.12%) holdings attract further institutional capital.

Threats

4 points
  • •Intense competition from established players could pressure market share and profitability.
  • •Evolving government regulations and policies pose risks to operations and pricing.

Segment-wise Financial Analysis

Financial Results

Balance Sheet

Standalone • Annual • All amounts in ₹ Crores • CA Schedule III Format

No Balance Sheet Data Available

Standalone annual data is not available for this symbol.
Try switching to Consolidated view.

Shareholding Pattern

Loading shareholding data...

Company Insider Trading Activity

Recent Insider Transactions

Insider NameTransaction DateFiling DateTotal SharesChangePriceAction
SUNEETA REDDY
11 Mar 202512 Mar 202548.34 L
40,000
₹6,135BUY
KARTHIK ANAND
19 Mar 202524 Mar 20253.46 L
929
₹6,415.5BUY
PPN POWER GENERATING CO PVT LTD
24 Mar 202527 Mar 20254,500
4,500
₹6,688.89BUY
PPN POWER GENERATING CO PVT LTD
28 Mar 202501 Apr 20255,827
1,327
₹6,556.14BUY
K VISHWESHWAR REDDY
04 Apr 202507 Apr 202515.77 L
1.50 L
₹6,714.67BUY

Corporate Action

Company Announcements

Technical Analysis & Indicators

Standard pivot points - most widely used

Pivot Points (CLASSIC)

LevelPriceDistance% Change
R4₹8058.67+₹255.67+3.28%
R3₹7958.67+₹155.67+1.99%
R2₹7914.33+₹111.33+1.43%
R1₹7858.67+₹55.67+0.71%
PIVOT₹7814.3311.330.15%
CURRENT₹7803.00--
S1₹7558.67-₹244.33-3.13%
S2₹7658.67-₹144.33-1.85%
S3₹7714.33-₹88.67-1.14%
S4₹7758.67-₹44.33-0.57%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: N/AP: N/ATC: N/A
R1
R2
R3
R4
indicator
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment

is trading CPR, indicating

● CPR Width

CPR is

● Opening Range

Day's range: ~

● Price Position

Trading Inside opening range

Delivery Volume Analysis & Trading Activity

Latest Volume
3.81L
(10 Mar 2026)
-17.8% vs avg
Delivery %
64.4%
(10 Mar 2026)
+1.4% vs avg
Avg Volume (20D)
4.64L
(10 Feb - 10 Mar)
20-day average
Avg Delivery %
63.0%
(10 Feb - 10 Mar)
Trend ↑
Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.

Peer Comparison & Industry Benchmarking

Quick Compare

Largest by Market Cap
Max Healthcare Institute Ltd
1.05L ₹ Cr
Best Profit Growth
Dr Agarwals Health Care Ltd
151.00 %
Highest Dividend Yield
Rainbow Childrens Medicare Ltd
0.51 %

Peer Comparison

Company Name
AGARWALEYE
Dr Agarwals Health Care Ltd
ASTERDM
Aster DM Healthcare Ltd
FORTIS
Fortis Healthcare Ltd
HCG
Healthcare Global Enterprises Ltd
JLHL
Jupiter Life Line Hospitals Ltd
JSLL
KIMS
Krishna Institute of Medical Sciences Ltd
MAXHEALTH
Max Healthcare Institute Ltd
MEDANTA
Global Health Ltd
NH
Narayana Hrudayalaya Ltd
RAINBOW
Rainbow Childrens Medicare Ltd

About

APOLLOHOSP

Apollo Hospitals Enterprise Ltd

Apollo Hospitals Enterprise Limited is a leading healthcare provider in India with an international presence. The company's core business revolves around delivering a wide spectrum of healthcare services, encompassing primary, secondary, and tertiary care. This includes a vast array of specialties, ranging from cardiology and oncology to neurosciences and robotic surgery, covering virtually all medical disciplines. Their facilities offer services like transplants, emergency care, and a comprehensive range of diagnostic procedures.

Apollo operates through several distinct segments. The primary segment, Healthcare Services, focuses on its network of hospitals and specialized facilities. Retail Health & Diagnostics encompasses the company's extensive network of pharmacies, clinics, diagnostic centers, and other retail healthcare outlets. The Digital Health & Pharmacy Distribution segment leverages technology through platforms like Apollo 24/7, its mobile health application, and www.apollopharmacy.in, its online pharmacy, to expand access and convenience. Finally, the "Others" segment encompasses diverse activities such as project consultancy, health insurance, medical colleges, and research services.

Beyond its core hospital and clinical services, Apollo's business model is diversified. It includes a substantial retail presence with pharmacies, primary care clinics, and specialized centers for areas such as birthing, dialysis, diabetes management, and dentistry. The company also engages in bio-banking of tissues, indicating a commitment to research and advanced medical technologies. Their educational arm, Medvarsity, provides e-learning opportunities, while their consultancy services extend beyond their direct patient care operations.

In summary, Apollo Hospitals' business strategy focuses on integrated healthcare delivery, combining advanced medical technologies with a broad network of facilities and digital platforms. This integrated approach encompasses a full spectrum of care, from primary healthcare to highly specialized treatments, and utilizes technological advancements to extend its reach and improve accessibility to healthcare services for a wide patient base. Their expansion into diverse related areas such as education, research, and retail demonstrates a comprehensive approach to the healthcare market.

COMPANY FACTS - APOLLOHOSP

Registered Address

"Ali Towers" Ill Floor, #55, Greams Road

Chennai

TAMIL NADU

IN

Tel: 914428290956

Website:https://www.apollohospitals.com/

Investor Relations:https://www.apollohospitals.com/corporate/investor-relations/financial-reports/
Company Details

Group: Health Care Equipment & Services

Sector: Health Care

Industry: Health Care Providers & Services

Exchange: NATIONAL STOCK EXCHANGE OF INDIA

Employees: 83,147

IPO Date: 23/05/1995

MANAGEMENT - APOLLOHOSP

Dr. Prathap Reddy

Executive Chairman of the Board, Founder

Smt. Preetha Reddy

Executive Vice Chairman of the Board

Shri. Krishnan Akhileswaran

Chief Financial Officer

Shri. S. M. Krishnan

Senior Vice President - Finance, Company Secretary

Smt. Sangita Reddy

Joint Managing Director, Executive Director

Smt. Suneeta Reddy

Managing Director, Executive Director

Shri. Bhaskara Mandavill Rao

Lead Non-Executive Independent Director

Smt. Shobana Kamineni

Non-Executive Non-Independent Director

Smt. Rama Bijapurkar

Non-Executive Independent Director

Dr. Murali Doraiswamy

Non-Executive Independent Director

Smt. V. Kavitha Dutt

Non-Executive Independent Director

Shri. Som Mittal

Non-Executive Independent Director

Investor Questions Answered

Apollo Hospitals Enterprise Ltd (APOLLOHOSP) Stock FAQs

Get answers to the most common questions about Apollo Hospitals Enterprise Ltd stock price, fundamentals, financial metrics, and investment analysis

The current share price of Apollo Hospitals Enterprise Ltd (APOLLOHOSP) is ₹7,803. Today, the stock has gained by ₹24.00 (0.31%), trading in a range of ₹7,770 to ₹7,870. The stock opened at ₹7,865 with a trading volume of 3,81,453 shares.
Apollo Hospitals Enterprise Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,09,228.89 crores, P/E ratio of 65.46, ROE of 10.02%, and ROCE of 16.60%. The dividend yield stands at 0.38%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Apollo Hospitals Enterprise Ltd (APOLLOHOSP) is ₹8,099.5, while the 52-week low is ₹6,002. Currently trading at ₹7,803, the stock is 85.9% away from its 52-week low and 3.7% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Apollo Hospitals Enterprise Ltd stock at ₹7,803 depends on multiple factors. The stock is currently trading with a P/E ratio of 65.46 and P/B ratio of N/A. Today's performance shows a gain of 0.31%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Apollo Hospitals Enterprise Ltd offers a dividend yield of 0.38%, which means for every ₹100 invested at the current price of ₹7,803, you can expect to receive approximately ₹0.38 annually as dividends. The face value of the stock is ₹5.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Apollo Hospitals Enterprise Ltd's key financial metrics include: P/E Ratio: 65.46, P/B Ratio: N/A, ROE: 10.02%, ROCE: 16.60%, Dividend Yield: 0.38%, EPS: ₹116.28, Book Value: ₹571.15, Debt-to-Equity: 0.96, and Current Ratio: N/A. The company's market cap stands at ₹1,09,228.89 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Apollo Hospitals Enterprise Ltd stock opened at ₹7,865 and is currently trading at ₹7,803, showing a gain of ₹24.00 (0.31%). The intraday high is ₹7,870 and low is ₹7,770. The trading volume stands at 3,81,453 shares, indicating moderate market participation today.
Apollo Hospitals Enterprise Ltd has a Price-to-Earnings (P/E) ratio of 65.46, which means investors are willing to pay ₹65.46 for every ₹1 of earnings. With an EPS of ₹116.28, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
Apollo Hospitals Enterprise Ltd has a market capitalization of ₹1,09,228.89 crores, making it a large-cap company. Market cap is calculated by multiplying the current stock price (₹7,803) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Apollo Hospitals Enterprise Ltd has a book value of ₹571.15 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹7,803, which is 1266.2% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Apollo Hospitals Enterprise Ltd has a Return on Equity (ROE) of 10.02% and Return on Capital Employed (ROCE) of 16.60%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These are moderate returns, suggesting decent operational efficiency. Higher percentages generally indicate better financial performance.
Apollo Hospitals Enterprise Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Apollo Hospitals Enterprise Ltd has a debt-to-equity ratio of 0.96, which measures the company's financial leverage by comparing total debt to shareholders' equity. This moderate ratio indicates balanced use of debt and equity. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Apollo Hospitals Enterprise Ltd has an Earnings Per Share (EPS) of ₹116.28, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹7,803 and P/E ratio of 65.46, investors are paying 65.46 times the annual earnings per share. This strong EPS indicates robust profitability. Track EPS growth over quarters to assess earnings momentum.
Apollo Hospitals Enterprise Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Apollo Hospitals Enterprise Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Apollo Hospitals Enterprise Ltd stock, consider: 1) Fundamental Analysis - Review P/E (65.46), ROE (10.02%), debt-to-equity (0.96), and growth rates. 2) Technical Analysis - Check 52-week range (₹6002.00 - ₹8099.50), moving averages, and chart patterns. 3) Valuation - Compare current price (₹7803.00) with book value (₹571.15) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Apollo Hospitals Enterprise Ltd share is ₹5.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹7,803 is 155960x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Apollo Hospitals Enterprise Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹6002.00 - ₹8099.50). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.96 indicates leverage. 4) Liquidity Risk - Based on trading volume of 3,81,453 shares. 5) Valuation Risk - P/E of 65.46 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Apollo Hospitals Enterprise Ltd operates in the industry with key metrics: P/E ratio of 65.46, ROE of 10.02%, market cap of ₹1,09,228.89 crores, and dividend yield of 0.38%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.96), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Apollo Hospitals Enterprise Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹7,803, with a 52-week range of ₹6002.00 to ₹8099.50. Based on fundamentals like P/E (65.46), ROE (10.02%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Apollo Hospitals Enterprise Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹7803.00. 2) Fundamental Deterioration - Declining ROE (currently 10.02%), increasing debt (D/E: 0.96), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Apollo Hospitals Enterprise Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.38%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.